These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 6838716
1. Can aversive properties of (peripherally-injected) vasopressin account for its putative role in memory? Ettenberg A, van der Kooy D, Le Moal M, Koob GF, Bloom FE. Behav Brain Res; 1983 Mar; 7(3):331-50. PubMed ID: 6838716 [Abstract] [Full Text] [Related]
2. Intracerebroventricular application of a vasopressin antagonist peptide prevents the behavioral actions of vasopressin. Ettenberg A. Behav Brain Res; 1984 Dec; 14(3):201-11. PubMed ID: 6549259 [Abstract] [Full Text] [Related]
3. Behavioral effects of peripheral administration of arginine vasopressin: a review of our search for a mode of action and a hypothesis. Le Moal M, Dantzer R, Mormède P, Baduel A, Lebrun C, Ettenberg A, van der Kooy D, Wenger J, Deyo S, Koob GF. Psychoneuroendocrinology; 1984 Dec; 9(4):319-41. PubMed ID: 6514931 [Abstract] [Full Text] [Related]
4. Specificity of aversive stimulus properties of vasopressin. Bluthé RM, Dantzer R, Mormède P, Le Moal M. Psychopharmacology (Berl); 1985 Dec; 87(2):238-41. PubMed ID: 3931152 [Abstract] [Full Text] [Related]
5. Effects of peripherally injected vasopressin and des-glycinamide vasopressin on the extinction of a spatial learning task in rats. Packard MG, Ettenberg A. Regul Pept; 1985 May; 11(1):51-63. PubMed ID: 4011956 [Abstract] [Full Text] [Related]
6. Aversive effects of subcutaneously injected vasopressin in the rat: independence of the ascending dorsal noradrenergic bundle. Tam FW, Chen C, Alpert JE, Iversen SD. Brain Res; 1985 Jun 24; 337(1):133-7. PubMed ID: 3924347 [Abstract] [Full Text] [Related]
7. Can vasopressin alone act as an unconditioned stimulus to produce passive avoidance behaviour in rats in a typical memory experiment? Ebenezer IS. Neuropharmacology; 1988 Sep 24; 27(9):903-7. PubMed ID: 3185866 [Abstract] [Full Text] [Related]
8. Vasopressin potentiation in the performance of a learned appetitive task: reversal by a pressor antagonist analog of vasopressin. Ettenberg A, Le Moal M, Koob GF, Bloom FE. Pharmacol Biochem Behav; 1983 Apr 24; 18(4):645-7. PubMed ID: 6867069 [Abstract] [Full Text] [Related]
9. Dose-related influence of arginine-vasopressin on a passive avoidance behavior: effect of rearing conditions. Crine AF. Prog Neuropsychopharmacol Biol Psychiatry; 1984 Apr 24; 8(3):379-84. PubMed ID: 6541358 [Abstract] [Full Text] [Related]
10. Failure of vasopressin to enhance memory in a passive avoidance task in rats. Sahgal A, Keith AB, Wright C, Edwardson JA. Neurosci Lett; 1982 Jan 22; 28(1):87-92. PubMed ID: 7063145 [Abstract] [Full Text] [Related]
11. Hippocampal lesions block behavioral effects of central but not of peripheral pre-test injection of arginine vasopressin in an appetitive learning task. Alescio-Lautier B, Devigne C, Soumireu-Mourat B. Behav Brain Res; 1987 Jan 22; 26(2-3):159-69. PubMed ID: 3426787 [Abstract] [Full Text] [Related]
18. Vasopressin pressor antagonist injected centrally reverses behavioral effects of peripheral injection of vasopressin, but only at doses that reverse increase in blood pressure. Lebrun C, Le Moal M, Koob GF, Bloom FE. Regul Pept; 1985 Jun 22; 11(2):173-81. PubMed ID: 4035008 [Abstract] [Full Text] [Related]
19. Vasopressin and amphetamine, but not desglycinamide vasopressin, impair positively reinforced visual attention performance in rats. Sahgal A. Behav Brain Res; 1988 Jul 22; 29(1-2):35-42. PubMed ID: 3401320 [Abstract] [Full Text] [Related]